Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Elias Campo
Affiliation
Institute for Biomedical Research August Pi I Sunyer
ORCID
Career Start Year
1981
Papers
757
H Index
121
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37881141
Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab.
Br J Haematol
2024
37560801
<i>BCL3</i> rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases.
Haematologica
2024
38017105
Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation.
Leukemia
2024
38055913
Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes.
J Clin Oncol
2024
37994105
Massive parallel sequencing unveils homologous recombination deficiency in follicular dendritic cell sarcoma.
Haematologica
2024
37942762
A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma.
Hematol Oncol
2024
36221796
Intravascular Large B-Cell Lymphoma Genomic Profile Is Characterized by Alterations in Genes Regulating NF-κB and Immune Checkpoints.
Am J Surg Pathol
2023
37803049
MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms.
Sci Rep
2023
37957421
The 2022 classifications of lymphoid neoplasms : Keynote.
Pathologie (Heidelb)
2023
37485564
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO.
Br J Haematol
2023
37746159
All-CLL: A Capture-based Next-generation Sequencing Panel for the Molecular Characterization of Chronic Lymphocytic Leukemia.
Hemasphere
2023
37947807
[Molecular diagnostics for vitreoretinal lymphoma].
Pathologie (Heidelb)
2023
37505099
IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia.
Blood Adv
2023
37974680
Laryngeal EBV-positive Inflammatory Follicular Dendritic cell/fibroblastic Reticular cell Tumour.
Indian J Otolaryngol Head Neck Surg
2023
37053555
Decoding the molecular heterogeneity of pediatric monomorphic post-solid organ transplant lymphoproliferative disorders.
Blood
2023
36989492
Chromatin activation profiling of stereotyped chronic lymphocytic leukemias reveals a subset 8-specific signature.
Blood
2023
36975733
Mutational Profile and Pathological Features of a Case of Interleukin-10 and RGS1-Positive Spindle Cell Variant Diffuse Large B-Cell Lymphoma.
Hematol Rep
2023
37304935
Robust CRISPR-Cas9 Genetic Editing of Primary Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Cells.
Hemasphere
2023
37031299
A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responses.
Leukemia
2023
37260508
RFcaller: a machine learning approach combined with read-level features to detect somatic mutations.
NAR Genom Bioinform
2023
36995085
Unraveling the genetics of transformed splenic marginal zone lymphoma.
Blood Adv
2023
36994552
Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.
Hematol Oncol
2023
36586001
Advances in the Classification of Myeloid and Lymphoid Neoplasms.
Virchows Arch
2023
36849712
Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortium.
Histopathology
2023
36716220
Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis.
Blood Adv
2023
36509891
Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma.
Leukemia
2023
36459219
Diffuse large B-cell lymphomas, not otherwise specified, and emerging entities.
Virchows Arch
2023
36635392
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.
Leukemia
2023
36633689
Correction to: Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation.
Virchows Arch
2023
36566271
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.
Leukemia
2023
36454275
Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation.
Virchows Arch
2023
36355424
MYC and TP53 Alterations but Not MAPK Pathway Mutations Are Common Oncogenic Mechanisms in Follicular Dendritic Cell Sarcomas.
Arch Pathol Lab Med
2023
34448823
The molecular hallmarks of primary and secondary vitreoretinal lymphoma.
Blood Adv
2022
35443168
Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral TÂ cell lymphoma.
Cell Rep
2022
35611996
Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia.
Hematol Oncol
2022
35504971
Publisher Correction: Signatures of TOP1 transcription-associated mutagenesis in cancer and germline.
Nature
2022
35672297
ATM germline variants in a young adult with chronic lymphocytic leukemia: 8â¿¿years of genomic evolution.
Blood Cancer J
2022
35609565
A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile.
Blood Adv
2022
35726449
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.
Am J Hematol
2022
35850118
NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma.
Hematol Oncol
2022
36480778
Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care.
JCO Precis Oncol
2022
36470887
Correction: ATM germline variants in a young adult with chronic lymphocytic leukemia: 8 years of genomic evolution.
Blood Cancer J
2022
36497332
Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements, Diffuse Large B-Cell Lymphoma with <i>MYC</i>-Rearrangement, and Diffuse Large B-Cell Lymphoma with <i>MYC</i>-Cluster Amplification.
Cancers (Basel)
2022
36001803
Genomic profiling for clinical decision making in lymphoid neoplasms.
Blood
2022
36000950
Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma.
Pediatr Blood Cancer
2022
35927489
Molecular map of chronic lymphocytic leukemia and its impact on outcome.
Nat Genet
2022
36030304
Response to "The WHO classification of haematolymphoid tumours" (Editorial).
Leukemia
2022
35953718
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia.
Nat Med
2022
35885481
Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma.
Diagnostics (Basel)
2022
35288589
PanCancer analysis of somatic mutations in repetitive regions reveals recurrent mutations in snRNA U2.
NPJ Genom Med
2022
1 - 50 of 757
Column Actions
Search
Recommended Authors
Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year
2013
Number of shared co-authors
3
Lauren C Chong
University of British Columbia
Career Start Year
2012
Number of shared co-authors
12
Xiaoqiong Wang
The University of Texas MD Anderson Cancer Center
Career Start Year
2011
Number of shared co-authors
0
David Wu
University of Washington
Career Start Year
2010
Number of shared co-authors
7
Alexandra E Kovach
Children's Hospital of Los Angeles
Career Start Year
2008
Number of shared co-authors
7
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year
2007
Number of shared co-authors
2
Jeremy C Wallentine
Intermountain Medical Center
Career Start Year
2007
Number of shared co-authors
1
Rashmi Kanagal-Shamanna
The University of Texas MD Anderson Cancer Center
Career Start Year
2006
Number of shared co-authors
5
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year
2006
Number of shared co-authors
4
Melissa H Cessna
Intermountain Medical Center
Career Start Year
2001
Number of shared co-authors
4
Trang Le
KTH - Royal Institute of Technology
Career Start Year
2000
Number of shared co-authors
0
Guang Fan
Oregon Health and Science University
Career Start Year
2000
Number of shared co-authors
3
Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year
2000
Number of shared co-authors
4
Ralf Kemmerling
Institute of Pathology, Paracelsus Medical University
Career Start Year
2000
Number of shared co-authors
1
Gyeongsin Park
Seoul St. Mary's Hospital, The Catholic University of Korea
Career Start Year
1999
Number of shared co-authors
0
Katia Basso
Institute for Cancer Genetics, Columbia University
Career Start Year
1999
Number of shared co-authors
4
Sze Fai Yip
Tuen Mun Hospital
Career Start Year
1999
Number of shared co-authors
1
Andrew M Evens
Rutgers Robert Wood Johnson Medical School
Career Start Year
1998
Number of shared co-authors
8
David M Weinstock
Merck & Co.
Career Start Year
1998
Number of shared co-authors
13
Eric Tse
School of Clinical Medicine, University of Hong Kong
Career Start Year
1997
Number of shared co-authors
3
Francisco Vega
The University of Texas MD Anderson Cancer Center
Career Start Year
1996
Number of shared co-authors
10
Jean Soulier
University of Paris
Career Start Year
1993
Number of shared co-authors
6
Christopher D Gocke
Johns Hopkins University School of Medicine
Career Start Year
1992
Number of shared co-authors
5
Wenbin Wei
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year
1991
Number of shared co-authors
1
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year
1988
Number of shared co-authors
7
David M Dorfman
Brigham and Women's Hospital and Harvard Medical School
Career Start Year
1982
Number of shared co-authors
3
Maryalice Stetler-Stevenson
National Cancer Institute, National Institutes of Health
Career Start Year
1981
Number of shared co-authors
12
Ulrich D??hrsen
University Hospital Essen, University of Duisburg-Essen
Career Start Year
1979
Number of shared co-authors
3
Dennis B Cornfield
Lehigh Valley Hospital
Career Start Year
1977
Number of shared co-authors
0
Robin Fo??
Sapienza University.
Career Start Year
1968
Number of shared co-authors
16
row(s) 1 - 30 of 30
Collaborators
Elaine S Jaffe
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
105
Louis M Staudt
National Cancer Institute, National Institutes of Health
Co-authored papers
78
Xose S Puente
University of Oviedo
Co-authored papers
44
Carlos L??pez-Ot??n
Instituto Universitario de Oncologia, Universidad de Oviedo
Co-authored papers
41
Reiner Siebert
Co-authored papers
29
V??ctor Quesada
Instituto Universitario de Oncologia, Universidad de Oviedo
Co-authored papers
16
Stefania Pittaluga
National Cancer Institute, National Institutes of Health
Co-authored papers
14
David W Scott
University of British Columbia
Co-authored papers
13
Marta Gut
Universitat de Barcelona (UB)
Co-authored papers
12
Wenming Xiao
Human Phenome Institute and Shanghai Cancer Center, Fudan University
Co-authored papers
11
Mark Raffeld
Center for Cancer Research, National Cancer Institute
Co-authored papers
11
Ivo Gut
Spain Universitat de Barcelona (UB)
Co-authored papers
10
David Torrents
Institucio Catalana de Recerca i Estudis Avancats (ICREA)
Co-authored papers
10
Simon Heath
Barcelona Institute of Science and Technology (BIST)
Co-authored papers
9
Panagiotis Baliakas
Uppsala University
Co-authored papers
8
Ander Diaz-Navarro
Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo
Co-authored papers
7
Xavier Estivill
Sidra Medical Center
Co-authored papers
7
Alfonso Valencia
Josep Carreras Leukaemia Research Institute (IJC)
Co-authored papers
7
Peter J Campbell
Wellcome Sanger Institute
Co-authored papers
7
Rafael Vald??s-Mas
Weizmann Institute of Science
Co-authored papers
6
Maria J Merino
National Cancer Institute, National Institutes of Health
Co-authored papers
6
Liming Yang
Co-authored papers
6
Hendrik G Stunnenberg
Co-authored papers
6
Richard Simon
National Cancer Institute
Co-authored papers
6
Montserrat Puiggròs
Co-authored papers
5
Paul Flicek
European Bioinformatics Institute
Co-authored papers
5
Roderic Guig??
Barcelona Institute of Science and Technology
Co-authored papers
5
Giorgio Inghirami
Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital
Co-authored papers
5
Michele Ceribelli
National Center for Advancing Translational Sciences
Co-authored papers
5
Diana Puente
Universitat Autonoma de Barcelona
Co-authored papers
5
1 - 30